Form 4 for BCDA BioCardia, Inc.
Accepted 2025-09-23 00:00:00 ET · period of report 2025-09-19 · accession 0001437749-25-029651 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-23 | 2025-09-19 | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $1.25 | +48.0K | 216.8K | +28% | +$60.0K |
| D | 2025-09-23 | 2025-09-19 | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | — | +48.0K | 143.6K | +50% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-19 | P | A | 48,000 | $1.25 | 216,762 | D | — | — | (F1) These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. |
| 2 | Derivative | Warrant (right to buy) | 2025-09-19 | P | A | 48,000 | — | 143,612 | D | $1.25 · 2025-09-19 to 2027-09-20 | 48,000 Common Stock | (F1) These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. |